Also from this source

You just read:

Amira Pharmaceuticals Announces the Nomination of an Orally Available Pre-Clinical Candidate in a New LPA-Related Program, an Autotaxin Inhibitor

News provided by

Amira Pharmaceuticals, Inc.

Dec 15, 2010, 11:37 EST